Intra-aortic balloon pump in acute chest pain and cardiogenic shock – a long-term follow-up

References

• Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991;325:1117–1122.
   PubMed Web of Science ®Google Scholar
• Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119:1211–1219.
   PubMed Web of Science ®Google Scholar
• Kolte D, Khera S, Dabhadkar KC, et al. Trends in coronary angiography, revascularization, and outcomes of cardiogenic shock complicating non-ST-elevation myocardial infarction. Am J Cardiol. 2016;117:1–9.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511–2515.
   PubMed Web of Science ®Google Scholar
• Lee L, Erbel R, Brown TM, et al. Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival. J Am Coll Cardiol. 1991;17:599–603.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Gupta N, Guo Y, et al. Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med. 2015;128:601–608.
   PubMed Web of Science ®Google Scholar
• Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–634.
   PubMed Web of Science ®Google Scholar
• Thiele H, Ohman EM, Desch S, et al. Management of cardiogenic shock. Eur Heart J. 2015;36:1223–1230.
   PubMed Web of Science ®Google Scholar
• Thiele H, Jobs A, Ouweneel DM, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J. 2017;38:3523–3531.
   PubMed Web of Science ®Google Scholar
• Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:113–118.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–1296.
   PubMed Web of Science ®Google Scholar
• Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382:1638–1645.
   PubMed Web of Science ®Google Scholar
• O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–e425.
   PubMed Web of Science ®Google Scholar
• van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the american heart association. Circulation. 2017;136:e232–e268.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–e161.
   PubMed Web of Science ®Google Scholar
• Tariq S, Aronow WS. Use of inotropic agents in treatment of systolic heart failure. Int J Mol Sci. 2015;16:29060–29068.
   PubMed Web of Science ®Google Scholar
• Kohl LP, Leimberger JD, Chiswell K, et al. Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial. Am Heart J. 2016;174:7–13.
   PubMed Web of Science ®Google Scholar
• Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:278–287.
   PubMed Web of Science ®Google Scholar
• Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019;139:1249–1258.
   PubMed Web of Science ®Google Scholar
• Katz SD, Smilowitz NR, Hochman JS. Another nail in the coffin for intra-aortic balloon counterpulsion in acute myocardial infarction with cardiogenic shock. Circulation. 2019;139:404–406.
   PubMedGoogle Scholar
• Chung BB, Sayer G, Uriel N. Mechanical circulatory support devices: methods to optimize hemodynamics during use. Expert Rev Med Devices. 2017;14:343–353.
   PubMed Web of Science ®Google Scholar
• Crespo-Leiro MG, Metra M, Lund LH, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20:1505–1535.
   PubMed Web of Science ®Google Scholar
• Romeo F, Acconcia MC, Sergi D, et al. Percutaneous assist devices in acute myocardial infarction with cardiogenic shock: review, meta-analysis. World J Cardiol. 2016;8:98–111.
   PubMed Web of Science ®Google Scholar
• Jeevanandam V, Song T, Onsager D, et al. The first-in-human experience with a minimally invasive, ambulatory, counterpulsation heart assist system for advanced congestive heart failure. J Heart Lung Transplant. 2018;37:1–6.
   PubMed Web of Science ®Google Scholar
• Thiele H, Akin I, Sandri M, et al. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699–1710.
   PubMed Web of Science ®Google Scholar
• Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (after eighty study): an open-label randomised controlled trial. Lancet. 2016;387:1057–1065.
   PubMed Web of Science ®Google Scholar